Scarica l'app Stockscreener
0.205
11.59%
0.0213
Dopo l'orario di chiusura:
.20
-0.005
-2.44%
Precedente Chiudi:
$0.1837
Aprire:
$0.1862
Volume 24 ore:
1.64M
Relative Volume:
0.37
Capitalizzazione di mercato:
$3.01M
Reddito:
$1.10M
Utile/perdita netta:
$-11.23M
Rapporto P/E:
-0.1012
EPS:
-2.025
Flusso di cassa netto:
$-6.61M
1 W Prestazione:
+13.26%
1M Prestazione:
-23.79%
6M Prestazione:
-66.02%
1 anno Prestazione:
-87.35%
Intervallo 1D:
$0.1811
$0.205
Intervallo di 1 settimana:
$0.173
$0.205
Portata 52W:
$0.173
$2.14
Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile
Nome
Matinas Biopharma Holdings Inc
Settore
Industria
Telefono
908-443-1860
Indirizzo
1545 Route 206 South, Suite 302, Bedminster, NJ
Compare MTNB vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MTNB
Matinas Biopharma Holdings Inc
|
0.205 | 2.70M | 1.10M | -11.23M | -6.61M | -2.025 |
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 132.08B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
984.04 | 62.71B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
136.62 | 54.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.35 | 44.51B | 742.00K | -1.37B | -1.07B | -7.0731 |
Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-05-11 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-08-26 | Ripresa | Piper Sandler | Overweight |
| 2020-01-27 | Iniziato | Piper Sandler | Overweight |
| 2020-01-24 | Iniziato | SunTrust | Buy |
| 2020-01-23 | Iniziato | SunTrust | Buy |
| 2020-01-09 | Iniziato | Aegis Capital | Buy |
| 2019-06-26 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Matinas Biopharma Holdings Inc Borsa (MTNB) Ultime notizie
Matinas BioPharma Faces NYSE American Compliance Challenges - TipRanks
Matinas BioPharma Receives New NYSE American Delisting Risk on Equity Shortfall - Minichart
Matinas BioPharma Receives NYSE American Noncompliance Notice for Continued Listing Standards - quiverquant.com
Matinas BioPharma Received Notice of Noncompliance - tradingview.com
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards - GlobeNewswire
symbol__ Stock Quote Price and Forecast - CNN
Matinas (MTNB) Results Review: EPS Lands Above Forecast in the Latest Reading; Closing Move: Shares Finish 1.16% Down at the ClosePerformance Review - vinanet.vn
Hydrogen startup GH Power lines up deal with Matinas BioPharma (NYSE: MTNB) - Stock Titan
Matinas (MTNB) Session: Finishes 1.16% Down at $0.20 on the Day; Levels: the Near-Term Reference Band Stretches From $0.19 to $0.21 in the Current UpdateWave Equality - vinanet.vn
Matinas (MTNB) Q4 2024 Earnings: EPS Beats Its Estimate at the Close; Market Response: Shares Move 8.93% Higher in the Latest ReadingWeak Earnings Momentum - vinanet.vn
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Top Premarket Decliners - marketscreener.com
Matinas (MTNB) Results Review: The Bottom-Line Figure Outpaces Its Comparison for the Current Session; Market Response: The Stock Loses 8.33%Earnings Trend Analysis - vinanet.vn
Matinas Biopharma Holdings Inc. (MTNB) Q4 2024 Earnings: Narrower Loss of -$0.82 Beats Estimates as Clinical Pipeline AdvancesRevenue Warning Signal - vinanet.vn
Matinas BioPharma (MTNB) holder Adam Stern details 9.99% stake and new warrants - Stock Titan
Matinas Biopharma (MTNB) Slips 2.6% to $0.26 as Micro-Cap Biotech Tests SupportZero Gamma Level - vinanet.vn
US Micro Cap StocksInvest from India - INDmoney
Matinas BioPharma Holdings Inc (MTNB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Enterprise value to revenue forward of Matinas BioPharma Holdings, Inc. – FWB:6LJ0 - TradingView
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Matinas BioPharma (MTNB) to merge into new GH Power International parent - stocktitan.net
MTNB Q4 2024 Earnings: Narrower-Than-Expected Loss Highlights Cost DisciplineDividend Increase Stocks - Vinanet
Matinas BioPharma (NYSE: MTNB) outlines GH Power deal and 91% post-merger stake - Stock Titan
Matinas BioPharma (MTNB) and GH Power set 91/9 split in NYSE American deal - Stock Titan
MTNB|Matinas BioPharma Holdings Inc|Price:0.335|Chg%:+0.093 - TradingKey
Matinas BioPharma Holdings Inc - TradingKey
Matinas BioPharma Holdings Inc (MTNB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Why Forte Biosciences Shares Are Trading Higher By 39%; Here Are 20 Stocks Moving Premarket - Benzinga
Matinas BioPharma Holdings Inc (MTNB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
12 Health Care Stocks Moving In Monday's Intraday SessionEntera Bio (NASDAQ:ENTX), Gossamer Bio (NASDA - Benzinga
Matinas BioPharma Holdings Inc (MTNB) Institutional Confidence - TradingKey
Matinas BioPharma Holdings Inc (MTNB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Matinas BioPharma Holdings Inc (MTNB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
Matinas Biopharma Holdings, Inc. Revenue Breakdown – AMEX:MTNB - TradingView
Trending Stocks Today | Matinas BioPharma Surges 44.65% Post-Market - Moomoo
Matinas BioPharma Ends At-The-Market Sales Agreement - TipRanks
Matinas BiopharmaBtig Terminates Sales Agreement With Matinas Biopharma Holdings, Effective Immediately On July 23, 2026SEC Filing - TradingView
Matinas BioPharma $50 Million ATM Program With BTIG Terminated With No Penalties - TradingView
Matinas BioPharma Announces Strategic Business Combination with GH Power to Create Publicly Traded, Advanced Clean Energy and Green Hydrogen Company; Signs Definitive Agreement to Sell LNC Platform Technology and Lead Product Candidate M - Hydrogen Central
[425] Matinas BioPharma Holdings, Inc. Business Combination Communication - Stock Titan
Matinas BioPharma Holdings Inc (NYSE: MTNB) Share Price, MTNB Stock News, MTNB Share Price & Updates - Kalkine
Matinas BioPharma (NYSE: MTNB) to combine with GH Power in new Ontario holdco - Stock Titan
GH Power Goes Public via Matinas BioPharma Merger - Fuel Cells Works
GH Power To Go Public Through Business Combination With Matinas BioPharma - Pulse 2.0
Nasdaq Surges Over 100 Points; Bank of America Earnings Top Views - Sahm
Hezbay builds 9.54% position in Matinas BioPharma (MTNB) - Stock Titan
Matinas BioPharma forms business tie-up with GH Power to create clean energy and green hydrogen company - ROI-NJ
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
United StatesLowenstein Represents Matinas BioPharma In Strategic Business Combination With GH Power And Divestiture Of Matinas BioPharma Nanotechnologies, Inc. - Mondaq
Matinas Biopharma Holdings Inc Azioni (MTNB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):